SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-042330
Filing Date
2021-08-09
Accepted
2021-08-09 07:01:24
Documents
14
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20210809.htm   iXBRL 8-K 37173
2 EX-99.1 stro-ex991_6.htm EX-99.1 207794
3 GRAPHIC gf3pnnesrryo000001.jpg GRAPHIC 8752
  Complete submission text file 0001564590-21-042330.txt   406188

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA stro-20210809.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20210809_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20210809_pre.xml EX-101.PRE 12084
7 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20210809_htm.xml XML 3679
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 211154567
SIC: 2836 Biological Products, (No Diagnostic Substances)